- Firm recruits Big-4 legal team including highly-regarded corporate partner David Morris
- Firm confirms aggressive growth plans for Sydney
Lander & Rogers has announced the recruitment of a team of leading M&A and equity capital markets lawyers into its Sydney corporate practice.
Joining the firm from KPMG Law, the team is led by David Morris who founded the commercial law practice of KPMG Law. Mr Morris was also the head of its M&A and corporate practice, joint leader of KPMG's global legal services M&A and corporate group, and a member of KPMG's global legal services leadership team.
Mr Morris will lead Lander & Rogers' Sydney corporate team, bringing decades of experience in building successful, client-centric corporate practices. Mr Morris will also play an integral role in implementing the firm's aggressive growth plans for its Sydney office.
Joining Mr Morris in his move to Lander & Rogers are senior corporate lawyers Paul Mayson, a highly experienced public and private M&A specialist; David Tink, who has extensive equity capital markets and corporate advisory experience in both Australia and the UK; and Bree Taylor, who practises in both M&A and equity capital markets.
Mr Morris and his team have acted on a number of significant recent transactions including the cross listing of AVITA Medical on ASX and NASDAQ; the sale of ASX-listed Redflex Holdings by scheme of arrangement; the listing of Clarity Pharmaceuticals on ASX, which is understood to be the largest ever clinical stage IPO on ASX; and the sale of the ONCALL Group to private equity funds managed by Pemba Capital Partners.
Mr Morris commented that the team was attracted to Lander & Rogers by "the firm's renowned culture of inclusion, its strong focus on building long-term client relationships, its clear growth strategy and its ability to be innovative and nimble in response to the constantly evolving needs of clients".
"Lander & Rogers has been one of the fastest growing firms in the Australian market in recent years and we are really excited to play an active role in the next stage of its growth journey," said Mr Morris.
Chief executive partner Genevieve Collins said, "Sydney is a key market for our clients, and there has been explosive growth in the volume and quality of corporate work we have been asked to undertake for our clients. We are delighted that David Morris, Paul Mayson, David Tink and Bree Taylor have joined us. The team's appointment illustrates our firm's strong commitment to growing our footprint in Sydney and is in direct response to the increasing needs of our clients for complex transactional support. David and his team represent another important step in growing our corporate practice, not only in Sydney but nationally".
Ms Collins also noted, "David Morris is recognised as a leading corporate lawyer, particularly in cross-border transactions between Australia and the US, and has led some of the region's largest and most complex matters during his career. This depth of knowledge and expertise will be of significant benefit to our clients and David's extensive leadership experience will also be invaluable to the firm as we embark on the next stage of our growth".
Corporate practice group leader Jackie Solakovski welcomed the new team and noted, "we are incredibly excited to have David Morris and his team join us. Our corporate practice has grown significantly in recent years and the addition of the new team will allow us to further accelerate this growth and provide our clients with an even broader range of services, particularly in the IPO and public markets transactional space".
The announcement follows the appointment of former Coles managing director John Durkan to the firm's board in October 2021.
Head of Client Engagement
M +61 414 572 434
E [email protected]
All information on this site is of a general nature only and is not intended to be relied upon as, nor to be a substitute for, specific legal professional advice. No responsibility for the loss occasioned to any person acting on or refraining from action as a result of any material published can be accepted.